Literature DB >> 28185915

Targeting kinase signaling pathways with constrained peptide scaffolds.

Laura E Hanold1, Melody D Fulton1, Eileen J Kennedy2.   

Abstract

Kinases are amongst the largest families in the human proteome and serve as critical mediators of a myriad of cell signaling pathways. Since altered kinase activity is implicated in a variety of pathological diseases, kinases have become a prominent class of proteins for targeted inhibition. Although numerous small molecule and antibody-based inhibitors have already received clinical approval, several challenges may still exist with these strategies including resistance, target selection, inhibitor potency and in vivo activity profiles. Constrained peptide inhibitors have emerged as an alternative strategy for kinase inhibition. Distinct from small molecule inhibitors, peptides can provide a large binding surface area that allows them to bind shallow protein surfaces rather than defined pockets within the target protein structure. By including chemical constraints within the peptide sequence, additional benefits can be bestowed onto the peptide scaffold such as improved target affinity and target selectivity, cell permeability and proteolytic resistance. In this review, we highlight examples of diverse chemistries that are being employed to constrain kinase-targeting peptide scaffolds and highlight their application to modulate kinase signaling as well as their potential clinical implications.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Constrained peptide; Kinase inhibitor; Peptide macrocycle; Stapled peptide

Mesh:

Substances:

Year:  2017        PMID: 28185915      PMCID: PMC5407947          DOI: 10.1016/j.pharmthera.2017.02.014

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  129 in total

Review 1.  Allosteric small-molecule kinase inhibitors.

Authors:  Peng Wu; Mads H Clausen; Thomas E Nielsen
Journal:  Pharmacol Ther       Date:  2015-10-24       Impact factor: 12.310

2.  Design of a selenylsulfide-bridged EGFR dimerization arm mimic.

Authors:  Laura E Hanold; Christopher P Watkins; Norman T Ton; Peter Liaw; Aaron M Beedle; Eileen J Kennedy
Journal:  Bioorg Med Chem       Date:  2015-03-20       Impact factor: 3.641

Review 3.  The history and future of targeting cyclin-dependent kinases in cancer therapy.

Authors:  Uzma Asghar; Agnieszka K Witkiewicz; Nicholas C Turner; Erik S Knudsen
Journal:  Nat Rev Drug Discov       Date:  2015-02       Impact factor: 84.694

4.  Evaluation of dimerization-inhibitory activities of cyclic peptides containing a β-hairpin loop sequence of the EGF receptor.

Authors:  Takaaki Mizuguchi; Naho Ohara; Mika Iida; Ryunosuke Ninomiya; Shinji Wada; Yoshiaki Kiso; Kazuki Saito; Kenichi Akaji
Journal:  Bioorg Med Chem       Date:  2012-08-17       Impact factor: 3.641

Review 5.  Enhancing the buccal mucosal delivery of peptide and protein therapeutics.

Authors:  Thiago Caon; Liang Jin; Cláudia M O Simões; Raymond S Norton; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2014-08-29       Impact factor: 4.200

Review 6.  Peptide stapling techniques based on different macrocyclisation chemistries.

Authors:  Yu Heng Lau; Peterson de Andrade; Yuteng Wu; David R Spring
Journal:  Chem Soc Rev       Date:  2014-09-08       Impact factor: 54.564

7.  β-hairpin peptide that targets vascular endothelial growth factor (VEGF) receptors: design, NMR characterization, and biological activity.

Authors:  Donatella Diana; Anna Basile; Lucia De Rosa; Rossella Di Stasi; Sara Auriemma; Claudio Arra; Carlo Pedone; Maria Caterina Turco; Roberto Fattorusso; Luca Domenico D'Andrea
Journal:  J Biol Chem       Date:  2011-10-03       Impact factor: 5.157

Review 8.  Enigmas in tumor resistance to kinase inhibitors and calculation of the drug resistance index for cancer (DRIC).

Authors:  C I Edvard Smith
Journal:  Semin Cancer Biol       Date:  2016-11-16       Impact factor: 15.707

9.  Engineered conformation-dependent VEGF peptide mimics are effective in inhibiting VEGF signaling pathways.

Authors:  Daniele Vicari; Kevin C Foy; Eric M Liotta; Pravin T P Kaumaya
Journal:  J Biol Chem       Date:  2011-02-14       Impact factor: 5.157

10.  Structure-activity relationships of peptidomimetics that inhibit PPI of HER2-HER3.

Authors:  Shanthi Kanthala; Ted Gauthier; Seetharama Satyanarayanajois
Journal:  Biopolymers       Date:  2014-06       Impact factor: 2.505

View more
  4 in total

Review 1.  Cell penetrating peptides to dissect host-pathogen protein-protein interactions in Theileria-transformed leukocytes.

Authors:  Malak Haidar; Perle Latré de Laté; Eileen J Kennedy; Gordon Langsley
Journal:  Bioorg Med Chem       Date:  2017-09-07       Impact factor: 3.641

2.  Identification of a RON tyrosine kinase receptor binding peptide using phage display technique and computational modeling of its binding mode.

Authors:  Omid Zarei; Silvia Benvenuti; Fulya Ustun-Alkan; Maryam Hamzeh-Mivehroud; Siavoush Dastmalchi
Journal:  J Mol Model       Date:  2017-08-19       Impact factor: 1.810

Review 3.  Potential for therapeutic targeting of AKAP signaling complexes in nervous system disorders.

Authors:  Angela R Wild; Mark L Dell'Acqua
Journal:  Pharmacol Ther       Date:  2017-12-17       Impact factor: 12.310

4.  Disruptors of AKAP-Dependent Protein-Protein Interactions.

Authors:  Ryan Walker-Gray; Tamara Pallien; Duncan C Miller; Andreas Oder; Martin Neuenschwander; Jens Peter von Kries; Sebastian Diecke; Enno Klussmann
Journal:  Methods Mol Biol       Date:  2022
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.